Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 263,119 shares of BLFS, which is worth approximately $6.95 Million. The most recent transaction as insider was on Apr 21, 2021, when has been sold 10,000 shares (Common Stock) at a price of $1.64 per share, resulting in proceeds of $16,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K

17.18% 3M change

4.93% 12M change

Total Value Held $6.95 Million

Aby J. Mathew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 21 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.34%	220,679 Common Stock
Apr 19 2021	SELL Open market or private sale	$326,200 $32.62 p/Share	10,000 Reduced 4.53%	210,679 Common Stock
Apr 19 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.34%	220,679 Common Stock
Apr 12 2021	BUY Grant, award, or other acquisition	-	3,360 Added 1.57%	210,679 Common Stock
Apr 01 2021	SELL Open market or private sale	$146,851 $36.53 p/Share	4,020 Reduced 1.96%	200,981 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	-	10,358 Added 4.67%	211,339 Common Stock
Mar 26 2021	SELL Open market or private sale	$105,590 $35.01 p/Share	3,016 Reduced 1.48%	200,981 Common Stock
Mar 24 2021	SELL Open market or private sale	$401,800 $40.18 p/Share	10,000 Reduced 4.67%	203,997 Common Stock
Mar 24 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.46%	213,997 Common Stock
Mar 22 2021	SELL Open market or private sale	$378,000 $37.8 p/Share	10,000 Reduced 4.67%	203,997 Common Stock
Mar 22 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.46%	213,997 Common Stock
Feb 26 2021	SELL Open market or private sale	$15,947 $39.57 p/Share	403 Reduced 0.2%	203,997 Common Stock
Feb 19 2021	SELL Open market or private sale	$192,713 $40.76 p/Share	4,728 Reduced 2.26%	204,400 Common Stock
Feb 18 2021	SELL Open market or private sale	$192,816 $40.67 p/Share	4,741 Reduced 2.22%	209,128 Common Stock
Feb 17 2021	SELL Open market or private sale	$192,792 $41.55 p/Share	4,640 Reduced 2.12%	213,869 Common Stock
Feb 08 2021	BUY Exercise of conversion of derivative security	-	33,196 Added 13.19%	218,509 Common Stock
Feb 08 2021	BUY Grant, award, or other acquisition	-	4,891 Added 2.57%	185,313 Common Stock
Feb 04 2021	SELL Open market or private sale	$739,690 $40.02 p/Share	18,483 Reduced 9.29%	180,422 Common Stock
Feb 04 2021	BUY Exercise of conversion of derivative security	$20,701 $1.12 p/Share	18,483 Added 8.5%	198,905 Common Stock
Feb 02 2021	SELL Open market or private sale	$743,611 $40.23 p/Share	18,484 Reduced 9.29%	180,422 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$20,702 $1.12 p/Share	18,484 Added 8.5%	198,906 Common Stock
Feb 01 2021	SELL Open market or private sale	$715,516 $38.71 p/Share	18,484 Reduced 9.29%	180,422 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$20,702 $1.12 p/Share	18,484 Added 8.5%	198,906 Common Stock
Dec 01 2020	SELL Open market or private sale	$13,486 $35.49 p/Share	380 Reduced 0.21%	180,422 Common Stock
Sep 29 2020	SELL Open market or private sale	$53,195 $28.63 p/Share	1,858 Reduced 1.02%	180,802 Common Stock

AJM

Aby J. Mathew

EVP & Chief Scientific Officer

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account